InformationSeekingMesolimbicEngagementStudy2
The Influence of Mesolimbic-hippocampal Interactions on Episodic Memory During Active Information Seeking
2 other identifiers
interventional
80
1 country
1
Brief Summary
Participants will complete a treasure task during neuroimaging where they have to learn which keys open a treasure chest, and then they are tested on the contents of the treasure chest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2023
CompletedFirst Submitted
Initial submission to the registry
January 31, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
September 5, 2025
August 1, 2025
2.8 years
January 31, 2024
August 28, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Mesolimbic Hippocampal Interactions
Functional Magnetic Resonance Imaging Activation characterizing Mesolimbic-Hippocampal Interactions
During Procedure
Episodic Memory
Item and Associative Memory for memoranda shown during the task
24-hours After Procedure
Study Arms (1)
Motivation
EXPERIMENTALTrials in which participants are motivated by hypothesis testing or not.
Interventions
Participants will be given cued instructions as to whether they are in a high or low motivation condition
Eligibility Criteria
You may qualify if:
- /40 far acuity (either corrected or uncorrected)
- In good medical health
You may not qualify if:
- History of head injury
- History of illness with Central Nervous Systems implications
- On Medications that Affect blood flow response and alertness
- Consumption of smoking and/or coffee 30 minutes prior to laboratory testing
- Placement of a device contraindicated for magnetic resonance imaging including cardia pacemaker, aneurysm clip, cochlear implants, pregnancy, intra-uterine device, shrapnel, metal fragments in the eyes, neurostimulators
- Weight \> 250lbs
- Claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Temple University
Philadelphia, Pennsylvania, 19122, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2024
First Posted
February 14, 2024
Study Start
October 24, 2023
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
September 5, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- Data will be shared within 1 year of study completion, and it will be available for at least 10 years.
Deidentified data will be shared on the open science framework.